Drug firm Alembic Pharmaceuticals on Monday said it has received final nod from the US health regulator for its Timolol Maleate ophthalmic gel-forming solution used for the treatment of elevated intraocular pressure. The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Timolol Maleate ophthalmic gel-forming solution, 0.25 per cent and 0.5 per cent, Alembic Pharma said in a filing to BSE.from IndiaTV India: Google News Feed https://ift.tt/3om4nG9
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.